Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
Tianyu Zhai,Xiaoyu Zhang,Zhenyu Hei,Longyang Jin,Chao Han,Audrey Tsznam Ko,Xiaofeng Yu,Jiandong Wang
DOI: https://doi.org/10.3389/fphar.2021.792330
IF: 5.6
2021-10-20
Frontiers in Pharmacology
Abstract:[This corrects the article DOI: 10.3389/fphar.2021.628621.].
pharmacology & pharmacy
What problem does this paper attempt to address?